Aadigen, LLC
USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Aadigen ranks #20,673 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.
- #20,673
- of 49,997 US assignees by volume
- 38th percentile
- by Innovation Score (31.5/100)
- 21.9
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R20673 · US Corporation #20,673 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 13 grants
- MID-PACK #20,673/49,997
- PHOTO-FINISH 480 Biomedical
- CPC-NARROW C07K · 5 areas
- INNOV-THIN 31.5/100
- CLAIMS-DENSE 21.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: 480 Biomedical Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Aadigen’s 31.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Aadigen
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Aadigen · this assignee 31
Aadigen · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Aadigen's Innovation Score is 31.5/100 (38th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Aadigen?
Each dot is one of Aadigen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aadigen’s own 21.9 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Aadigen's grants concentrate
Aadigen, LLC is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Aadigen sits between 480 Biomedical Inc. and Abbyson Living LLC.
Aadigen's three-year grant acceleration
Aadigen, LLC shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Aadigen's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- 480 Biomedical
480 Biomedical Inc.
13 patents
- 7D Surgical ULC
7D Surgical ULC
13 patents
- @PAY IP Holdings
@PAY IP Holdings LLC
13 patents
- A&P Technology
A&P Technology, Inc.
13 patents
- Aamp of Florida
Aamp of Florida, Inc.
13 patents
- AB Enzymes OY
AB Enzymes OY
13 patents
- ABB K K
ABB K.K.
13 patents
- Abbyson Living
Abbyson Living LLC
13 patents
- Aadigen ◀
Aadigen, LLC
13 patents
What this shows Aadigen holds 13 patents at rank #20,675, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Aadigen
By rank, the assignees closest to #20,675 in granted patent volume.
- 480 Biomedical Inc. #20,671 · 13 patents
- 7D Surgical ULC #20,672 · 13 patents
- @PAY IP Holdings LLC #20,673 · 13 patents
- A&P Technology, Inc. #20,674 · 13 patents
- Aamp of Florida, Inc. #20,676 · 13 patents
- AB Enzymes OY #20,677 · 13 patents
- ABB K.K. #20,678 · 13 patents
- Abbyson Living LLC #20,679 · 13 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Aadigen's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Aadigen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 38th percentile higher than 38% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 7.7% |
| 2017 | 3 | 23.1% |
| 2018 | 2 | 15.4% |
| 2019 | 3 | 23.1% |
| 2020 | 2 | 15.4% |
| 2023 | 1 | 7.7% |
| 2025partial year | 1 | 7.7% |
Which technologies does Aadigen, LLC patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Aadigen, LLC's patent record in context - here's where to go next.
- Aadigen, LLC's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #20,673 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Aadigen, LLC against 480 Biomedical Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.